Results 211 to 220 of about 5,255,725 (300)

National Practice Patterns of VA ECMO and Left Ventricular Mechanical Unloading for Cardiogenic Shock

Artificial Organs, EarlyView.
Consensus surrounding the management of VA ECMO and left ventricular mechanical unloading for cardiogenic shock (CS) is limited. We thus conducted a national survey of practice patterns in the treatment of CS to characterize such variability, finding large heterogeneity in CS diagnosis, VA ECMO initiation, and LVMU strategies.
Dustin M. Anderson‐Bell, Morgan M. Millar, Rachel R. Codden, Stavros Drakos, Craig Selzman, Chloe R. Skidmore, Margaret Carlson, Frederick Welt, Tom Hanff, Hiroshi Kagawa, Jason Glotzbach, Andrea Steely, Vikas Sharma, Matt Goodwin, Daniel Haase, Jason Carr, Joseph E. Tonna   +16 more
wiley   +1 more source

Cellular and Molecular Profiling of Native Heart Valves in Infective Endocarditis: A Comparative Study with Calcific Aortic Valve Disease. [PDF]

Biomedicines
Sinitskaya A, Khutornaya M, Poddubnyak A, Asanov M, Kostyunin A, Tupikin A, Kabilov M, Sinitsky M.   +7 more
europepmc   +1 more source

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

Artificial Organs, EarlyView.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci, Anne‐Kristin Schaefer, Thomas Schlöglhofer, Emilio Osorio‐Jaramillo, Amila Kahrovic, Alvaro Perazzo, Marcus Granegger, Daniel Zimpfer, Dominik Wiedemann, Julia Riebandt   +9 more
wiley   +1 more source

Macrophages as key modulators of calcific aortic valve disease. [PDF]

Front Cardiovasc Med
Issa N, Blot G, Candellier A, Boudot C, Louvet L, Kamel S, Bennis Y, Hénaut L.   +7 more
europepmc   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

Artificial Organs, EarlyView.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah, Ezin Deniz, Sara Knigge, Jasmin Hanke, Alina Zubarevich, Mohamad Dia, Chaikovska Sofia, Todurov Borys, Saeed Torabi, Bastian Schmack, Alexander Weymann, Zurab Darbaidze, Josephina Haunschild, Christian D. Etz, Max Biewer, Arjang Ruhparwar, Jan D. Schmitto, Günes Dogan   +17 more
wiley   +1 more source

Employment of the Ascending Aortic Volume as a Predictor of Adverse Outcomes in Patients With Bicuspid Aortic Valve Disease. [PDF]

Rev Cardiovasc Med
Li H, Hu Y, Yuan H, Chen T, Zhuang J.
europepmc   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

Artificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov, Sara Yousefzada, Isabell A. Just, Christoph Klein, Evgenij Potapov, Santiago Garcia, Dhairya Patel, Lauren S. Ranard, Arseniy Goncharov, Dean J. Kereiakes, Raj R. Makkar, Torsten P. Vahl, Tanja K. Rudolph, Axel Unbehaun   +13 more
wiley   +1 more source

Rare type I collagen variants in early-onset bicuspid aortic valve disease: Overlap with Ehlers-Danlos syndrome and osteogenesis imperfecta. [PDF]

HGG Adv
Mansoorshahi S, Pensa CT, Carter E, Sabate-Rotes A, Michelena HI, Yetman AT, De Backer J, Mosquera LM, Bissell MM, Andreassi MG, Foffa I, Hui DS, Caffarelli A, Kim YY, Citro R, De Marco M, Tretter JT, McBride KL, Body SC, Raggio C, Milewicz DM, Prakash SK, EBAV Investigators.   +22 more
europepmc   +1 more source

A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation

British Journal of Haematology, EarlyView.
Primary antiphospholipid syndrome comprises distinct inflammatory subgroups defined by cytokine profiling. A shared pro‐inflammatory signature is present across all patients, whereas arterial thrombosis demonstrates enhanced inflammatory activation compared with venous thrombosis, suggesting divergent pathogenic mechanisms and opportunities for ...
Catherine B. Ducker, Megan V. Preece, Jeremy Schofield, Charis Pericleous, Mike Laffan, Simon Abrams, Deepa J. Arachchillage   +6 more
wiley   +1 more source

Insights into preclinical models of calcific aortic valve disease and their translational potential. [PDF]

Front Cardiovasc Med
Lafosse I, Mentaverri R, Avondo C, Bennis Y, Tribouilloy C, Hénaut L.   +5 more
europepmc   +1 more source